Cover Image

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin

Abstract Background Epilepsy is a neurological disorder with a multitude of underlying causes, which may include infection with Onchocerca volvulus, the parasitic worm that causes human onchocerciasis. A survey carried out in 1989 revealed a high prevalence of epilepsy (1.02% overall, ranging from 0...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bruno P. Mmbando (Author), Patrick Suykerbuyk (Author), Mohamed Mnacho (Author), Advocatus Kakorozya (Author), William Matuja (Author), Adam Hendy (Author), Helena Greter (Author), Williams H. Makunde (Author), Robert Colebunders (Author)
Format:	Book
Published:	BMC, 2018-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
by: Christoph Kaiser, et al.
Published: (2019)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
by: Gasim Abd-Elfarag, et al.
Published: (2018)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021)

Attitudes and perceptions towards epilepsy in an onchocerciasis-endemic region of Tanzania: a mixed approach to determine the magnitude and driving factors
by: Vivian P. Mushi, et al.
Published: (2024)

Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor.
by: Luís-Jorge Amaral, et al.
Published: (2023)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
by: Evy Lenaerts, et al.
Published: (2018)

High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
by: Bethany Levick, et al.
Published: (2017)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
by: Housseini Dolo, et al.
Published: (2018)

Onchocerciasis-associated epilepsy and biomarkers.
by: Robert Colebunders, et al.
Published: (2024)

Onchocerciasis-associated epilepsy and biomarkers
by: Robert Colebunders, et al.
Published: (2024)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
by: Sarah O'Neill, et al.
Published: (2019)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
by: Robert Colebunders, et al.
Published: (2024)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
by: Michel Mandro, et al.
Published: (2018)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
by: Nolbert Gumisiriza, et al.
Published: (2020)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

Report of the first international workshop on onchocerciasis-associated epilepsy
by: Robert Colebunders, et al.
Published: (2018)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009)

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
by: Adam M. Fimbo, et al.
Published: (2022)

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
by: Mamadou O Traore, et al.
Published: (2012)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys.
by: Sébastien D S Pion, et al.
Published: (2009)

Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
by: Arnauld Efon-Ekangouo, et al.
Published: (2023)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania
by: Adam M. Fimbo, et al.
Published: (2023)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
by: Robert Colebunders, et al.
Published: (2019)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
by: Natalie V. S. Vinkeles Melchers, et al.
Published: (2018)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

The onchocerciasis hypothesis of nodding syndrome.
by: Robert Colebunders, et al.
Published: (2023)

Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
by: Samuel Wanji, et al.
Published: (2018)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017)